New monoclonal antibody can detect ERG oncoprotein in prostate cancer patients

A media release from the Uniformed Services University of the Health Sciences last week announced the development of a highly specific assay for the detection of ERG oncoprotein. The assay is based on the development of an anti-ERG monoclonal antibody that appears to be capable of detecting the presence of ERG oncoprotein with > 99 percent accuracy. … READ MORE …

The continuing search for better diagnostic tests

In the continuing search for tests that will do a better job than the PSA test of defining clinically significant prostate cancer (as opposed to indolent disease) while it is still in its earliest possible stages, two new papers have provided information based on laboratory (not clinical studies). … READ MORE …

Prostate cancer news reports: Tuesday, August 11, 2009

Today’s news items deal with:

  • The effect of dutasteride on the results of PCA3 tests
  • How common is the TMPRSS2 fusion gene in men with prostate cancer in North America?
  • Can prostate biopsy data predict laterality of prostate cancer with accuracy? … READ MORE …

Prostate cancer news reports: Sunday, May 24, 2009

Today’s news reports deal with such matters as:

  • Advances in radical prostatectomy
  • Variations in mutation in androgen-resistant patients
  • Data from a Phase I/II trial of AT-101
  • The link between CTC level and response to therapy with abiraterone … READ MORE …

Prostate cancer news reports: Friday, May 22, 2009

Today’s news reports cover items on:

  • Gene expression and prostate cancer progression
  • Risk of complications from in-office prostate biopsy
  • Post-RALP voiding function
  • Urinary toxicities after IMRT-SIB
  • Drugs in development for CRPC … READ MORE …